Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Palliative care: an update on "terminal restlessness"

A L Burke1

  • 1Bethlehem Hospital, Caulfield, VIC.

The Medical Journal of Australia
|January 6, 1997
PubMed
Summary

Terminal restlessness, a form of delirium in end-of-life care, can be effectively managed. Benzodiazepines offer palliation without worsening myoclonus or convulsions, unlike other antipsychotics.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Terminal restlessness--its management and the role of midazolam.

The Medical journal of Australia·1991
Same author

Counselling the elderly on nutrition in a community health care system.

Journal of the American Geriatrics Society·1978
See all related articles

Area of Science:

  • Palliative Care
  • Neuroscience
  • Geriatrics

Background:

  • Terminal restlessness is a common symptom in patients nearing the end of life.
  • It is considered a variant of delirium.
  • Reversible causes must be addressed.

Purpose of the Study:

  • To evaluate the efficacy of benzodiazepines in managing terminal restlessness.
  • To compare benzodiazepine treatment with other psychotropic medications.

Main Methods:

  • Literature review of studies on terminal restlessness management.
  • Analysis of treatment outcomes for different pharmacological interventions.

Main Results:

  • Benzodiazepines provide effective palliation for terminal restlessness.
  • Unlike haloperidol and phenothiazines, benzodiazepines do not increase the risk of myoclonus and convulsions.

Conclusions:

  • Benzodiazepines are a preferred pharmacological option for terminal restlessness.
  • Treatment should focus on symptom relief and avoiding adverse effects like myoclonus and seizures.

Related Experiment Videos